Human Herpesvirus 8–Positive Castleman Disease in Human Immunodeficiency Virus–Infected Patients: The Impact of Highly Active Antiretroviral Therapy
Laurent Aaron(Hôpital Necker-Enfants Malades), Jean Paul Viard(Hôpital Necker-Enfants Malades), Olivier Lidove(Groupe Hospitalier Diaconesses Croix Saint-Simon), B. Dupont(Délégation Paris 5), Laurent Roudière(Hôpital Necker-Enfants Malades), Chérine Yousry(Hôpital Necker-Enfants Malades)
Cited by 66
Related Papers
Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007
|Clinical Microbiology and Infection|2011|752
Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections
|Clinical Infectious Diseases|2003|680
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
|Clinical Infectious Diseases|2008|469
Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children
|The Pediatric Infectious Disease Journal|2002|436